Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1046-1053

  Freedman, David S ^a   Otvos, James D ^b   Jeyarajah, Elias J ^b   Barboriak, Joseph J ^c   Anderson, Alfred J ^d   Walker, John A ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d St Luke's Hospital Milwaukee   (United States)

Author keywords

Angiography; Coronary disease; Lipoprotein subfractions; Lipoproteins; Nuclear magnetic resonance spectroscopy

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT;

EID: 0031902649     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1046     Document Type: Article

References (25)

1. National Cholesterol Education Program Working Group on Lipoprotein Measurement. Recommendations on Lipoprotein Measurement. Bethesda, Md: National Heart, Lung, and Blood Institute. NIH publication No. 95-3044. 1995.
2. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-1345.
3. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iana A. Clearance of chylomicron remnant in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 1996;312:936-939.
4. Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol. 1995;6:209-214.
5. Havel RJ. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation. 1990;82:694-696.
6. Freedman DS, Croft J, Anderson AJ, Byers T, Jacobsen SJ, Gruchow HW, Barboriak JJ. The association of coronary artery disease with levels of total and high-density lipoprotein cholesterol. Epidemiology. 1994;5:80-87.
7. Grover SA, Coupal L, Hu XP. Identifying adults at increased risk of coronary disease: how well do the current cholesterol guidelines work? JAMA. 1995;274:801-806.
8. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem. 1988;34(suppl):B78-B83.
9. Fievet C, Fruchart JC. HDL heterogeneity and coronary heart disease. Diabetes Metab Rev. 1991;7:155-162.
10. Krauss RM, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol. 1992;3:377-383.
11. Rajman I, Maxwell S, Cramb R, Kendall M. Particle size: the key to the atherogenic lipoprotein? Q J Med. 1994;87:709-720.
12. Wilson HM, Patel JC, Skinner ER. The distribution of high-density lipoprotein subfractions in coronary survivors. Biochem Soc Trans. 1990;18:1175-1176.
13. Williams PT, Krauss RM, Vranizan KM, Stefanick ML, Wood PDS, Lindgren FT. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler Thromb. 1992;12:332-340.
14. Austin MA, Breslow JL, Hennekens CH, During JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
15. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67-80.
16. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
17. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:1687-1697.
18. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subtractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
19. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.
20. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
21. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupin PJ, Dispers JP. Small, dense, low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69-75.
22. Miller NE. Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589-597.
23. Cheung MC, Brown BG, Wolf AC, Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res. 1991;32:383-394.
24. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb. 1991;11:174-182.
25. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem. 1991;37:377-386.